Rob,
This is the image now in my mind: Douglas Murphy-Chutorian and Ed Pendergast are facing each other with pistols. Murphy-Chutorian gets off the first shot, but Pendergast fires a split second later. Flags pop out of the pistols, reading "Lancet" and "NEJM." Neither goes down, but Murphy-Chutorian snarls, "See ya next quarter, tenderfoot."
SO. Both procedures work just fine, and the subtle differences in technique make little difference when it comes to the endpoints, which we knew all along. The machines are then, in a sense, a commodity. Who can offer the best deal to their customers? That would be the winner. It is my understanding that ESTI's system is cheaper, and we know PTMR is less invasive. We should be able to handicap this horse race pretty well in a couple of quarters. There may be room for both companies for a while. One company will get regulatory approval in one country before the other and have first to market advantages, etc. Once the market approaches saturation . . .
I still think the best approach is to own both companies, and I'll have dry powder for that strategy in a couple of weeks.
Check ya Later, Tuck |
